Microbot Medical Inc. MBOT
1.28
(0.03)
(2.29%)
as of 25 Sep
- Market cap
- $88.0M
- P/E
- 0.0×
Follow MBOT
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(31.87%) | (32.42%) | (27.58%) | (32.91%) | |
| (30.06%) | (30.01%) | (26.09%) | (30.68%) | ||
ROIC |
0.00% | 0.00% | (506.63%) | (850.51%) | |
Return on Tangible Assets |
(16.77%) | (17.18%) | (19.38%) | (23.82%) | |
Average Days of Receivables |
— | — | 198.47 | 155.51 | |
Free Cash Flow per Share |
(0.23) | (0.29) | (0.23) | (0.27) | |
Free Cash Flow |
(11.02) | (13.11) | (15.38) | (17.93) | |
Capital Expenditures |
(0.04) | (0.06) | (0.15) | (0.29) | |
Piotroski F-Score |
— | — | 4.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
(6.93%) | (8.32%) | (10.33%) | (12.92%) | |
Accounts Receivable Turnover |
— | — | 0.87 | 2.36 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.27 | 1.50 | |
Inventory Turnover |
— | — | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 2,276.01 | 307.76 | |
Days of Inventory on Hand |
— | 0.00 | 4,734.51 | 1,027.16 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 3,167.79% | 1,420.24% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 5,140.86% | 2,904.62% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 529.78% | 295.09% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.84 | 0.99 | 1.07 | 1.08 | |
Depreciation/Fixed assets |
0.81 | 0.51 | 0.23 | 0.15 | |
Capex/Depreciation |
(0.67) | (1.28) | (3.52) | (6.13) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.01 | |
Operating CF per Share |
(0.23) | (0.28) | (0.23) | (0.26) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.80 | 0.70 | |
Net Profit Margin |
0.00% | 0.00% | (7,359.92%) | (3,955.22%) |
Columns are period end dates